Search

Your search keyword '"Christos E. Kyriakopoulos"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Christos E. Kyriakopoulos" Remove constraint Author: "Christos E. Kyriakopoulos"
21 results on '"Christos E. Kyriakopoulos"'

Search Results

1. PARP inhibitors in metastatic prostate cancer

2. A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

3. A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy

5. Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

6. Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

7. A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

8. Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma

9. Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

10. Data from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

11. Data from A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

12. Supplemental Figure 2 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

13. Data from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

14. Supplemental Figure 1 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

15. Supplemental Figure 3 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

17. Neutropenic Fever–Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic

18. Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

19. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis

20. Post-traumatic splenic cysts treated with laparoscopy: two case reports

21. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

Catalog

Books, media, physical & digital resources